Form 4: Coupang Director Neil Mehta and Greenoaks Capital Partners Sell Shares
SEC Form 4
Director Neil Mehta and Greenoaks Capital Partners LLC report the sale of Coupang, Inc. Class A Common Stock in multiple transactions on March 14, 2024.
Summary
- Neil Mehta, a director of Coupang, Inc., and Greenoaks Capital Partners LLC reported the sale of Class A Common Stock on March 14, 2024.
- The sales were executed in multiple transactions at varying prices.
- Mr. Mehta serves as a Managing Director of Greenoaks Capital.
- The reported transactions involved the sale of 1,000,000 shares at a weighted average price of $18.6007, 540,341 shares at $18.7468, and 59,659 shares at $19.5187.
- Following the transactions, Mr. Mehta indirectly beneficially owns 48,006,135 shares of Class A Common Stock.
- Mr. Mehta also holds 51,396 restricted stock units.
- Greenoaks Capital may be deemed a director by deputization due to Mr. Mehta's board service.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a sale of shares by a director and a related entity. It's a neutral event in itself, with no inherent positive or negative sentiment.
Industry Context
Sales of shares by directors and major shareholders are a common occurrence and are publicly disclosed to ensure transparency. The impact on the stock price depends on the size of the sale relative to the overall trading volume and market sentiment.
Comparison to Industry Standards
- Share sales by insiders are a regular part of the market, with companies like Amazon, Alibaba, and Sea Limited seeing similar transactions by their executives and major shareholders.
- The scale of these sales is not unusual for directors of large, publicly traded companies.
Stakeholder Impact
- The sale of shares by a director could potentially influence investor sentiment, although the impact is likely to be minimal given the size of the company and the volume of shares traded daily.
- The disclosure ensures transparency for all stakeholders.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Date of the reported transactions (sale of shares). |
| 03/18/2024 | Date of signature for the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.